AG Barra

Research Group of Lena Barra

"Understanding the genetic and enzymatic basis of non-canonical natural product biosynthetic pathways will enable the development of novel biocatalysts for sustainable production of pharmaceuticals, as well as the genome-based discovery of novel lead structures for drug development". 

"Understanding the genetic and enzymatic basis of non-canonical natural product biosynthetic pathways will enable the development of novel biocatalysts for sustainable production of pharmaceuticals, as well as the genome-based discovery of novel lead structures for drug development".